NEW MJ NEWS

AbbVie to Host Second-Quarter 2023 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its second-quarter 2023 financial results on Thursday, July 27, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2023-earnings-conference-call-301867373.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CGRW Announces LUA Approval

CannaGrow Holdings Announces LUA Approval and Issuance of CUP for Colorado Buffalo…

$AFI: Abbattis Bioceuticals Claim Against Affinor Growers is Unlawful and Dismissed in Court

Abbattis Bioceuticals Unlawful Claim Against Affinor Growers Dismissed Without Prejudice in Court…

Trulieve Cannabis Corp. (TCNNF) Announces the Largest US Cannabis Transaction; Acquisition of Harvest Health & Recreation Inc.

Trulieve Announces the Largest US Cannabis Transaction; Acquisition of Harvest Health &…

$MJMJ Executes Contract to Purchase The Adagio

The MaryJane Group, Inc. Executes Contract to Purchase The Adagio  DENVER–(BUSINESS WIRE)–…